Vetia launches first and only vaccine against major intestinal infections in suckling piglets

Vetia Animal Health expands the catalog of biological products for pigs Porvaxin Rota+Coli+Closan innovative vaccine designed to combat the main pathogens of intestinal infections in suckling piglets.

Porvaxin Rota+Coli+Clos is an inactivated vaccine containing most common adhesion factors in suckling piglets (F4ac, F5, F6 and F41); Rotavirus suit

serogroup A; And Clostridia perfringens type C, β-toxoid.

The vaccine is administered intramuscular route pregnant sows for passive immunization of piglets in order to reduce clinical manifestations and mortality caused by these pathogens.

The triple protection provided by Porvaxin Rota+Coli+Clos covers the need for simplify vaccination protocols due to fewer applications, which simplifies work. Vaccine comes in 25 doses

and ready to use.

Neonatal diarrhea in piglets is common problem in pig farming resulting in high mortality and morbidity, creating serious animal welfare problems and causing significant economic loss to producers. Vaccination of pregnant mothers is a key measure to control these processes in suckling piglets.

“With this launch of Vetia strengthens its commitment to the pig sector

to offer effective and safe solutions that simplify daily work and improve the well-being of animals,” they note.